Democrats Celebrate Walgreens and CVS Selling Abortion Drugs to Kill Babies

National   |   Micaiah Bilger   |   Feb 17, 2023   |   11:04AM   |   Washington, DC

A group of Democrat attorneys general thanked the pharmacy chains Walgreens and CVS this week for their decision to begin selling abortion drugs.

In a letter Thursday, the attorneys general from 22 states and the District of Columbia asserted that the abortion drugs mifepristone and misoprostol are very safe and much-needed now that more than a dozen states ban killing unborn babies in abortions, The Hill reports.

“In a time when access to abortion is under attack—now more than ever in the past 50 years—we stand in full support of pharmacies like Walgreens and CVS becoming FDA-certified to dispense and mail these essential medications and to make them available as broadly as possible,” they wrote.

In January, WalgreensCVS and, later, RiteAid announced plans to begin selling abortion drugs that are used to kill unborn babies up to 10 weeks of pregnancy. Their decisions came after the Biden administration dropped safety regulations for the dangerous abortion drug mifepristone, which has been linked to the deaths of millions of babies and dozens of women. Previously, mifepristone only could be dispensed by FDA-approved abortion facilities, medical offices and hospitals under the direct supervision of a licensed physician.

Since the announcements, pro-life leaders have launched boycotts and protests against the pharmacy chains all across the country. Earlier this month, 20 Republican state attorneys general also wrote to the companies, warning that selling abortion drugs through the mail is “unsafe and illegal” and the companies could face lawsuits.

Please follow LifeNews on Rumble for the latest pro-life videos.

This week, the Democrat attorneys general criticized their Republican counterparts for attacking “reproductive health care” and scaring companies that want to provide it.

“There are some that have threatened legal repercussions to these companies, which is merely another effort to restrict the freedoms of Americans nationwide and to generate an aura of fear around reproductive health care,” Nevada Attorney General Aaron D. Ford said in a statement.

Others who signed the letter included the attorneys general of California, Oregon, Washington, Arizona, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, North Carolina, Pennsylvania, Rhode Island and Vermont, according to 2 News.

None of the pharmacy chains have begun selling abortion drugs yet. According to the Washington Examiner, a Walgreens spokesperson said earlier this month that “we are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws.”

The drug mifepristone, typically used with a second drug, misoprostol, now is used for more than half of all abortions in the U.S. every year, or nearly half a million unborn babies, according to the Guttmacher Institute.

The FDA has linked mifepristone to at least 28 women’s deaths and 4,000 serious complications between 2000 and 2018. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.

Right now, a federal judge is considering a lawsuit from four medical groups that challenges the FDA approval of mifepristone as an abortion drug. The medical organizations accused the agency of ignoring evidence of safety problems and failing to properly study the risks.

Studies indicate the risks are more common than what abortion activists often claim, with as many as one in 17 women requiring hospital treatment. A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.

Another new study from the University of Toronto, “Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion,” published in the Annals of Internal Medicine, found that one in ten women who took the abortion pill had to go to the emergency room, according to Pregnancy Help News.